FindTrial
Sign In

The role of refractory cardiogenic shock in refractory cardiogenic shock based on ECMO team building: a prospective two-center observational study

The role of refractory cardiogenic shock in refractory cardiogenic shock based on ECMO team building: a prospective two-center observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062824
Enrollment
Unknown
Registered
2022-08-19
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory cardiogenic shock

Interventions

Surviving shock Extra-corporea lMembrane Oxygenation (ECMO) system group:Surviving shock Extra-corporea lMembrane Oxygenation (ECMO) system

Sponsors

Shunde Hospital, Southern Medical University (the First People’s Hospital of Shunde)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Patients diagnosed as refractory cardiogenic shock; 3. Those who need to sign the informed consent form during ECMO treatment.

Exclusion criteria

Exclusion criteria: None.

Design outcomes

Primary

MeasureTime frame
hospital mortality;—

Countries

China

Contacts

Public ContactLiuer Zuo

Shunde Hospital, Southern Medical University (the First People’s Hospital of Shunde)

13500276597@163.com+86 13500276597

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026